SK Bioscience Forecast, price target & analysts
SK Bioscience Target price 2024 - Analyst rating & recommendation
SK Bioscience Classifications & Recommendation:
SK Bioscience Price Target
| Target Price | KRW46,000.00 |
| Price | KRW50,400.00 |
| Deviation |
8.73%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target SK Bioscience 2025 .
The average SK Bioscience target price is KRW46,000.00.
This is
8.73%
register free of charge
KRW60,000.00
19.05%
register free of charge
KRW37,000.00
26.59%
register free of charge
|
|
| A rating was issued by 3 analysts: 0 Analysts recommend SK Bioscience to buy, 1 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the SK Bioscience stock has an average upside potential 2025 of
8.73%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Billion KRW | 369.51 | 221.38 |
| 19.10% | 40.09% | |
| EBITDA Margin | -2.37% | -37.84% |
| 112.25% | 1,496.04% | |
| Net Margin | 6.04% | -34.84% |
| 77.49% | 676.50% |
3 Analysts have issued a sales forecast SK Bioscience 2024 . The average SK Bioscience sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an SK Bioscience EBITDA forecast 2024. The average SK Bioscience EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast SK Bioscience 2024 . The average SK Bioscience net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share KRW | 290.65 | -1,004.00 |
| 81.79% | 445.43% | |
| P/E | negative | |
| EV/Sales | 12.57 |
1 Analysts have issued a SK Bioscience forecast for earnings per share. The average SK Bioscience <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the SK Bioscience stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
